159 related articles for article (PubMed ID: 19946037)
21. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual.
Vilá LM; Alarcón GS; McGwin G; Bastian HM; Fessler BJ; Reveille JD;
Arthritis Rheum; 2006 Oct; 55(5):799-806. PubMed ID: 17013840
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus--a 5-yr prospective study.
Stoll T; Sutcliffe N; Mach J; Klaghofer R; Isenberg DA
Rheumatology (Oxford); 2004 Aug; 43(8):1039-44. PubMed ID: 15161983
[TBL] [Abstract][Full Text] [Related]
23. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population.
Jonsson H; Nived O; Sturfelt G
Medicine (Baltimore); 1989 May; 68(3):141-50. PubMed ID: 2785628
[TBL] [Abstract][Full Text] [Related]
24. [Significance of damage index in predicting systemic lupus erythematosus outcome].
Tarasova IA; Ivanova MM; Zhorniak AP; Nasonova VA
Ter Arkh; 2003; 75(1):59-62. PubMed ID: 12652960
[TBL] [Abstract][Full Text] [Related]
25. Accrual of organ damage over time in patients with systemic lupus erythematosus.
Gladman DD; Urowitz MB; Rahman P; Ibañez D; Tam LS
J Rheumatol; 2003 Sep; 30(9):1955-9. PubMed ID: 12966597
[TBL] [Abstract][Full Text] [Related]
26. Systemic lupus erythematosus in a multiethnic US cohort. XXXIII. Clinical [corrected] features, course, and outcome in patients with late-onset disease.
Bertoli AM; Alarcón GS; Calvo-Alén J; Fernández M; Vilá LM; Reveille JD;
Arthritis Rheum; 2006 May; 54(5):1580-7. PubMed ID: 16645994
[TBL] [Abstract][Full Text] [Related]
27. Recurrent major infections in juvenile-onset systemic lupus erythematosus--a close link with long-term disease damage.
Lee PP; Lee TL; Ho MH; Wong WH; Lau YL
Rheumatology (Oxford); 2007 Aug; 46(8):1290-6. PubMed ID: 17522097
[TBL] [Abstract][Full Text] [Related]
28. Current causes of death in systemic lupus erythematosus in Europe, 2000--2004: relation to disease activity and damage accrual.
Nossent J; Cikes N; Kiss E; Marchesoni A; Nassonova V; Mosca M; Olesinska M; Pokorny G; Rozman B; Schneider M; Vlachoyiannopoulos PG; Swaak A
Lupus; 2007; 16(5):309-17. PubMed ID: 17576731
[TBL] [Abstract][Full Text] [Related]
29. Summarizing disease features over time: II. Variability measures of SLEDAI-2K.
Ibañez D; Gladman D; Urowitz M
J Rheumatol; 2007 Feb; 34(2):336-40. PubMed ID: 17183620
[TBL] [Abstract][Full Text] [Related]
30. SLICC/ACR Damage Index in Afro-Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteroid therapy, and prognosis.
Nossent JC
J Rheumatol; 1998 Apr; 25(4):654-9. PubMed ID: 9558165
[TBL] [Abstract][Full Text] [Related]
31. Initial and accrued damage as predictors of mortality in Brazilian patients with systemic lupus erythematosus: a cohort study.
Cardoso CR; Signorelli FV; Papi JA; Salles GF
Lupus; 2008 Nov; 17(11):1042-8. PubMed ID: 18852231
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
[TBL] [Abstract][Full Text] [Related]
33. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
[TBL] [Abstract][Full Text] [Related]
34. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus.
Brunner HI; Feldman BM; Bombardier C; Silverman ED
Arthritis Rheum; 1999 Jul; 42(7):1354-60. PubMed ID: 10403262
[TBL] [Abstract][Full Text] [Related]
35. Influenza virus vaccination of patients with systemic lupus erythematosus: effects on disease activity.
Abu-Shakra M; Zalmanson S; Neumann L; Flusser D; Sukenik S; Buskila D
J Rheumatol; 2000 Jul; 27(7):1681-5. PubMed ID: 10914851
[TBL] [Abstract][Full Text] [Related]
36. Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort.
Petri M; Genovese M
J Rheumatol; 1992 Oct; 19(10):1559-65. PubMed ID: 1464868
[TBL] [Abstract][Full Text] [Related]
37. Systemic lupus erythematosus in a multiethnic US cohort LUMINA LI: anaemia as a predictor of disease activity and damage accrual.
Bertoli AM; Vilá LM; Apte M; Fessler BJ; Bastian HM; Reveille JD; Alarcón GS;
Rheumatology (Oxford); 2007 Sep; 46(9):1471-6. PubMed ID: 17650522
[TBL] [Abstract][Full Text] [Related]
38. Predictors of damage progression in Portuguese patients with systemic lupus erythematosus.
Santos MJ; Vinagre F; Nero P; Barcelos F; Barcelos A; Rodrigues AM; de Matos AA; Silva C; Miranda L; Capela S; Marques A; Branco J; da Silva JC
Ann N Y Acad Sci; 2009 Sep; 1173():822-8. PubMed ID: 19758234
[TBL] [Abstract][Full Text] [Related]
39. Lymphopenia is associated with neuropsychiatric manifestations and disease activity in paediatric systemic lupus erythematosus patients.
Yu HH; Wang LC; Lee JH; Lee CC; Yang YH; Chiang BL
Rheumatology (Oxford); 2007 Sep; 46(9):1492-4. PubMed ID: 17673480
[TBL] [Abstract][Full Text] [Related]
40. Flares in pediatric systemic lupus erythematosus.
Weiss JE; Sison CP; Ilowite NT; Gottlieb BS; Eberhard BA
J Rheumatol; 2007 Jun; 34(6):1341-4. PubMed ID: 17477466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
